VIEW INC (VIEW)       0.7906  +0.06 (+7.55%)

0.7906  +0.06 (+7.55%)

US92671V1061 - Common Stock - After market: 0.7801 -0.01 (-1.33%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to VIEW. VIEW was compared to 41 industry peers in the Building Products industry. VIEW has a bad profitability rating. Also its financial health evaluation is rather negative. VIEW is valued quite expensive, but it does show an excellent growth.

Note: VIEW has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of VIEW is 3.00. This is a low score and indicates issues in the health and profitability of VIEW.

VS Industry

Valuation

Valuation Rating

3

When comparing the current price to the book value of VIEW, it is valued rather cheaply. It is trading at 0.61 times its book value.
When comparing the price book ratio of VIEW to the average industry price book ratio of 2.65, VIEW is valued rather cheaply. VIEW is also cheaper than 94% of the companies listed in the same industry.

VIEW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VIEW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry

Price/Book (0.61) VS Industry: 94% outperformed.

12.69
0.42

Growth

Growth Rating

9

The Earnings Per Share has grown by an impressive 26.08% over the past year.
Based on estimates for the next 5 years, VIEW will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.82% on average per year.
VIEW shows a strong growth in Revenue. In the last year, the Revenue has grown by 79.58%.

The Revenue has been growing by 54.22% on average over the past 5 years. This is a very strong growth!
The Revenue is expected to grow by 60.37% on average over the next 5 years. This is a very strong growth
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 26.08% -1.69% 17.17% 19.82% N/A
RevenueN/A 54.22% 79.58% 49.42% 70.63% 70.17% 60.37%

Health

Health Rating

3

The Quick Ratio of VIEW is much better than the industry average of 1.16.
With a Debt to Equity ratio of 0.05, VIEW is one of the better performing companies in its industry. It outperforms 84% of its industry peers.
VIEW has a Current Ratio of 1.43. This is a normal value and indicates that VIEW is financially healthy and should not expect problems in meeting its short term obligations.
VIEW has a Quick Ratio of 1.23. This is a normal value and indicates that VIEW is financially healthy and should not expect problems in meeting its short term obligations.

Compared to an average industry Current Ratio of 1.92, VIEW is worse placed to pay its short term obligations than its industry peers. 88% of its industry peers have a better Current Ratio.
VIEW has an Altman-Z score of -9.28. This is a bad value and indicates that VIEW is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 3.58, VIEW is in worse financial state than most of its industry peers. 100% of its industry peers have a better Altman-Z score.
VIEW has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of VIEW.
VS Industry

Debt/Equity (0.05) VS Industry: 84% outperformed.

3.27
0.00

Quick Ratio (1.23) VS Industry: 62% outperformed.

0.42
14.31

Current Ratio (1.43) VS Industry: 12% outperformed.

1.04
27.43

Altman-Z (-9.28) VS Industry: 0% outperformed.

-9.28
16.38

Dividend

Dividend Rating

0

VIEW does not give a dividend.

VIEW INC0.7906

NASDAQ:VIEW (1/27/2023, 7:00:02 PM)+0.06 (+7.55%)

After market: 0.7801 -0.01 (-1.33%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Capital Goods
GICS Industry Building Products
Earnings (Last) 11-08 2022-11-08/amc Earnings (Next) 05-29 2023-05-29
Inst Owners 59.75% Inst Owner Change 0%
Ins Owners 3.96% Ins Owner Change -26.44%
Market Cap 175.12M Analysts 43.33
Price Target 3.06 (287.05%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -1.54%
Min EPS beat(2) -8.54% Max EPS beat(2) 5.46%
EPS beat(4) 1 Avg EPS beat(4) -17.59%
Min EPS beat(4) -55.23% Max EPS beat(4) 5.46%
Revenue beat(2) N/A Avg Revenue beat(2) -27.07%
Min Revenue beat(2) -29.53% Max Revenue beat(2) -24.61%
Revenue beat(4) 2 Avg Revenue beat(4) -4.96%
Min Revenue beat(4) -29.53% Max Revenue beat(4) 26.68%
PT rev (1m) 0% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.05
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM) -1.28 EY N/A
EPS(NY) -0.75 Fwd EY N/A
FCF(TTM) -1.36 FCFY N/A
OCF(TTM) -1.25 OCFY N/A
SpS 0.39 BVpS 1.3
TBVpS 1.3 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM N/A
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 3 Asset Turnover 0.19

Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.97%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 1.23
Altman-Z -9.28
F-Score 3 WACC 19.88%
ROIC/WACC N/A Cap/Depr(3y) 232.41%
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 26.08% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 32.5%
EPS Next Y -1.69% EPS Next 2Y 17.17%
EPS Next 3Y 19.82% EPS Next 5Y N/A
Revenue growth 1Y 79.58% Revenue growth 3Y 54.22%
Revenue growth 5Y N/A Revenue growth Q2Q 25.83%
Revenue Next Year 49.42% Revenue Next 2Y 70.63%
Revenue Next 3Y 70.17% Revenue Next 5Y 60.37%
EBIT growth 1Y -34.53% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year 4.89%
EBIT Next 3Y 20.46% EBIT Next 5Y 19.88%
FCF growth 1Y N/A FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y N/A
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA